5-[(3,5-Dichloro-4-pyridyl)sulfanyl]-N-(1-methylpiperidin-4-yl)-4-nitrothiophene-2-carboxamide

ID: ALA2159501

Chembl Id: CHEMBL2159501

Cas Number: 1247823-70-6

PubChem CID: 60207396

Max Phase: Preclinical

Molecular Formula: C16H16Cl2N4O3S2

Molecular Weight: 447.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCC(NC(=O)c2cc([N+](=O)[O-])c(Sc3c(Cl)cncc3Cl)s2)CC1

Standard InChI:  InChI=1S/C16H16Cl2N4O3S2/c1-21-4-2-9(3-5-21)20-15(23)13-6-12(22(24)25)16(26-13)27-14-10(17)7-19-8-11(14)18/h6-9H,2-5H2,1H3,(H,20,23)

Standard InChI Key:  DMPNZWATLDPOGT-UHFFFAOYSA-N

Associated Targets(Human)

USP7 Tchem Ubiquitin carboxyl-terminal hydrolase 7 (837 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
USP47 Tchem Ubiquitin carboxyl-terminal hydrolase 47 (99 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CASP3 Tchem Caspase-3 (3632 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.37Molecular Weight (Monoisotopic): 446.0041AlogP: 4.33#Rotatable Bonds: 5
Polar Surface Area: 88.37Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.38CX Basic pKa: 8.44CX LogP: 3.27CX LogD: 2.19
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.54Np Likeness Score: -1.52

References

1. Weinstock J, Wu J, Cao P, Kingsbury WD, McDermott JL, Kodrasov MP, McKelvey DM, Suresh Kumar KG, Goldenberg SJ, Mattern MR, Nicholson B..  (2012)  Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.,  (10): [PMID:24900381] [10.1021/ml200276j]
2. Li P, Liu HM..  (2020)  Recent advances in the development of ubiquitin-specific-processing protease 7 (USP7) inhibitors.,  191  [PMID:32092586] [10.1016/j.ejmech.2020.112107]

Source